Hazte socio de la SAMFyC

Última publicación SAMFyC: Actualización en MF y APS

 

AULA VIRTUAL SAMFyC

Aula de formación virtual de SAMFyC

SAMFyC CONGRESOS

Historico de Comunicaciones
presentadas a los Congresos
Andaluces de MFyC (SAMFyC), desde 2008.


* * * * * * * * * * * * * * * * * * * * * * * * *

Información Socios

Ofertas de Trabajo
Ofertas de Trabajo SOCIOS SAMFYC

¡Actualiza tus datos!
Actualiza tus datos

 

Buscador de Contenidos

Sociedades Federadas

Medicina Familiar y Comunitaria

Sociedades Científicas de Medicina Familiar y Comunitaria

Enlaces de Interés

Consulte Nuestros Enlaces.
Enlaces de Interés

Acceso Socios



Buscador de publicaciones externas y alertas bibliográficas

Julio 2013 PDF Imprimir E-mail
Lunes, 05 de Agosto de 2013 00:00

Volver

SELECCIÓN DE REFERENCIAS BIBLIOGRÁFICAS DE LO PUBLICADO EN RELACIÓN CON ATENCIÓN PRIMARIA

Selección realizada por Antonio Manteca González

Chou R, Dana T, Bougatsos C, Blazina I, Starmer AJ, Reitel K, et al. Pressure ulcer risk assessment and prevention: a systematic comparative effectiveness review. Ann Intern Med. 2013; 159:28-38 [M,II]

23817702             R/C

VALORACIÓN Y PREVENCIÓN DEL RIESGO DE ÚLCERA POR PRESIÓN: REVISIÓN SISTEMÁTICA DE EFECTIVIDAD COMPARADA

 

Screening for HIV: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2013; 159:I-36 [M,II]

23817719

CRIBAJE DEL VIH: DECLARACIÓN DE RECOMENDACIÓN DEL US PREVENTIVE SERVICES TASK FORCE

 

Smith ME, Totten A, Hickam DH, Fu R, Wasson N, Rahman B, et al. Pressure ulcer treatment strategies: a systematic comparative effectiveness review. Ann Intern Med. 2013; 159:39-50 [M,II]

23817703             R/C

ESTRATEGIAS DE TRATAMIENTO DE LA ÚLCERA POR PRESIÓN: REVISIÓN SISTEMÁTICA DE EFECTIVIDAD COMPARADA

 

Cook NR, Lee IM, Zhang SM, Moorthy MV, Buring JE. Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial. Ann Intern Med. 2013; 159:77-85 [EC,II]

23856681             R/C

ASPIRINA EN BAJA DOSIS EN DÍAS ALTERNOS Y RIESGO DE CÁNCER: SEGUIMIENTO OBSERVACIONAL A LARGO PLAZO DE UN ENSAYO ALEATORIZADO

 

Donovan L, Hartling L, Muise M, Guthrie A, Vandermeer B, Dryden DM. Screening tests for gestational diabetes: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2013; 159:115-122 [M,II]

23712349             R/C

PRUEBAS DE CRIBAJE DE LA DIABETES GESTACIONAL: REVISIÓN SISTEMÁTICA PARA EL US PREVENTIVE SERVICES TASK FORCE

 

Hartling L, Dryden DM, Guthrie A, Muise M, Vandermeer B, Donovan L. Benefits and harms of treating gestational diabetes mellitus: a systematic review and meta-analysis for the U.S. Preventive Services Task Force and the National Institutes of Health Office of Medical Applications of Research. Ann Intern Med. 2013; 159:123-129 [M,II]

23712381             R/C

BENEFICIOS Y PERJUICIOS DE TRATAR LA DIABETES MELLITUS GESTACIONAL: REVISIÓN SISTEMÁTICA Y METAANÁLISIS PARA EL US PREVENTIVE SERVICES TASK FORCE Y EL DEPARTAMENTO DE APLICACIONES MÉDICAS DE LA INVESTIGACIÓN DE LOS NIH

 

Rothwell PM. Alternate-day, low-dose aspirin and cancer risk. Ann Intern Med. 2013; 159:148-150 [AO,I]

23856684

ASPIRINA EN DOSIS BAJAS EN DÍAS ALTERNOS Y RIESGO DE CÁNCER

 

Brown MT, Murphy FT, Radin DM, Davignon I, Smith MD, West CR. Tanezumab reduces osteoarthritic hip pain: results of a randomized, double-blind, placebo-controlled phase III trial. Arthritis Rheum. 2013; 65:1795-1803 [EC,I]

23553790             R/C

EL TANEXUMAB REDUCE EL DOLOR DE ARTROSIS DE CADERA: RESULTADOS DE UN ENSAYO ALEATORIZADO CONTROLADO CON PLACEBO A DOBLE CIEGO EN FASE III

 

Wenger A, Wirth W, Hudelmaier M, Noebauer-Huhmann I, Trattnig S, Bloecker K, et al. Meniscus body position, size, and shape in persons with and persons without radiographic knee osteoarthritis: quantitative analyses of knee magnetic resonance images from the osteoarthritis initiative. Arthritis Rheum. 2013; 65:1804-1811 [T,I]

23529645             R/C

POSICIÓN, TAMAÑO Y FORMA DEL CUERPO MENISCAL EN PERSONAS CON Y SIN ARTROSIS DE RODILLA RADIOGRÁFICA: ANÁLISIS CUANTITATIVO DE IMÁGENES DE RESONANCIA MAGNÉTICA DE RODILLA DE LA INICIATIVA DE ARTROSIS

 

Soni A, Batra RN, Gwilym SE, Spector TD, Hart DJ, Arden NK, et al. Neuropathic features of joint pain: a community-based study. Arthritis Rheum. 2013; 65:1942-1949 [T,I]

23553508             R/C

CARACTERÍSTICAS NEUROPÁTICAS DEL DOLOR ARTICULAR: ESTUDIO BASADO EN LA COMUNIDAD

 

Russ TC, Stamatakis E, Hamer M, Starr JM, Kivimäki M, Batty GD. Socioeconomic status as a risk factor for dementia death: individual participant meta-analysis of 86 508 men and women from the UK. Br J Psychiatry. 2013203:10-17. doi [M,II]

23818534             R/C

ESTATUS SOCIOECONÓMICO COMO FACTOR DE RIESGO DE MUERTE POR DEMENCIA: METAANÁLISIS DE PARTICIPANTES INDIVIDUALES DE 86.508 HOMBRES Y MUJERES DEL RU

 

Vaz Jdos S, Kac G, Emmett P, Davis JM, Golding J, Hibbeln JR. Dietary patterns, n-3 fatty acids intake from seafood and high levels of anxiety symptoms during pregnancy: findings from the Avon longitudinal study of parents and children. PLoS One. 2013; 8:e67671 [T,I]

23874437             R/C

PAUTAS DIETÉTICAS, INGESTA DE ÁCIDOS GRASOS N3 DE PESCADO Y SÍNTOMAS DE NIVELES ELEVADOS DE ANSIEDAD DURANTE EL EMBARAZO: HALLAZGOS DEL ESTUDIO LONGITUDINAL DE PADRES Y NIÑOS AVON

 

Uprichard WO, Uprichard J. Investigating microcytic anaemia. BMJ. 2013; 346:f3154 [R,I]

23747966

INVESTIGAR LA ANEMIA MICROCÍTICA

 

Day RO, Graham GG. Non-steroidal anti-inflammatory drugs (NSAIDs). BMJ. 2013; 346:f3195 [R,I]

23757736

AINE

 

Wiener RS, Schwartz LM, Woloshin S. When a test is too good: how CT pulmonary angiograms find pulmonary emboli that do not need to be found. BMJ. 2013; 347:f3368 [R,I]

23820021

CUANDO UNA PRUEBA ES DEMASIADO BUENA: CÓMO LOS ANGIOTAC PULMONARES HALLAN ÉMBOLOS PULMONARES QUE NO ES PRECISO HALLAR

 

Thachil J, Fitzmaurice D. Thrombocytopenia in an adult. BMJ. 2013; 346:f3407 [R,I]

23751903

TROMBOCITOPENIA EN UN ADULTO

 

Hull SC, Colloca L, Avins A, Gordon NP, Somkin CP, Kaptchuk TJ, et al. Patients' attitudes about the use of placebo treatments: telephone survey. BMJ. 2013; 347:f3757 [T,I]

23819963             R/C

ACTITUDES DE LOS PACIENTES RESPECTO LOS TRATAMIENTOS CON PLACEBO: ENCUESTA TELEFÓNICA

 

Sarri G, Westby M, Bermingham S, Hill-Cawthorne G, Thomas H; Guideline Development Group. Diagnosis and management of chronic hepatitis B in children, young people, and adults: summary of NICE guidance. BMJ. 2013; 346:f3893 [M,III]

23804177

DIAGNÓSTICO Y TRATAMIENTO DE LA HEPATITIS B EN NIÑOS, JÓVENES Y ADULTOS: RESUMEN DE LA GUÍA NICE

 

Bay B, Mortensen EL, Hvidtjørn D, Kesmodel US. Fertility treatment and risk of childhood and adolescent mental disorders: register based cohort study. BMJ. 2013; 347:f3978 [S,I]

23833075             R/C

TRATAMIENTO DE FERTILIDAD Y RIESGO DE TRASTORNOS MENTALES EN LA INFANCIA Y ADOLESCENCIA: ESTUDIO DE COHORTE BASADA EN REGISTRO

 

Carville S, Harker M, Henderson R, Gray H; Guideline Development Group. Acute management of myocardial infarction with ST-segment elevation: summary of NICE guidance. BMJ. 2013; 347:f4006 [M,III]

23843545

TRATAMIENTO AGUDO DEL INFARTO DE MIOCARDIO CON ELEVACIÓN DEL SEGMENTO ST: RESUMEN DE LA GUÍA NICE

 

Collis E, Al-Qurainy R. Care of the dying patient in the community. BMJ. 2013; 347:f4085 [R,II]

23823993

ATENCIÓN AL PACIENTE MORIBUNDO EN LA COMUNIDAD

 

Drug and Therapeutics Bulletin. Management of infantile colic. BMJ. 2013; 347:f4102 [R,I]

23843563

TRATAMIENTO DEL CÓLICO INFANTIL

 

Glasziou P, Moynihan R, Richards T, Godlee F. Too much medicine; too little care. BMJ. 2013; 347:f4247 [AO,I]

23820022

DEMASIADA MEDICINA; DEMASIADOS POCOS CUIDADOS

 

Baxter R, Bartlett J, Rowhani-Rahbar A, Fireman B, Klein NP. Effectiveness of pertussis vaccines for adolescents and adults: case-control study. BMJ. 2013; 347:f4249 [CC,I]

23873919             R/C

EFECTIVIDAD DE LA VACUNA DE LA TOS FERINA EN ADOLESCENTES Y ADULTOS: ESTUDIO CASO CONTROL

 

Marsden G, Perry M, Kelley K, Davies AH; Guideline Development Group. Diagnosis and management of varicose veins in the legs: summary of NICE guidance. BMJ. 2013; 347:f4279 [M,III]

23884969

DIAGNÓSTICO Y MANEJO DE LAS VENAS VARICOSAS EN LAS PIERNAS: RESUMEN DE LA GUÍA NICE

 

Moynihan R, Glassock R, Doust J. Chronic kidney disease controversy: how expanding definitions are unnecessarily labelling many people as diseased. BMJ. 2013; 347:f4298 [AO,II]

23900313

LA CONTROVERSIA DE LA ENFERMEDAD RENAL CRÓNICA: CÓMO EL EXPANDIR LAS DEFINICIONES ESTÁ ETIQUETANDO INNECESARIAMENTE COMO ENFERMAS A MUCHAS PERSONAS

 

Krafft A. Iron supplementation in pregnancy. BMJ. 2013; 347:f4399 [AO,I]

23843551

SUPLEMENTOS DE HIERRO EN EL EMBARAZO

 

Bridgewater B, Irvine D, Keogh B. NHS transparency. BMJ. 2013; 347:f4402 [AO,I]

23836717

TRANSPARENCIA DEL NHS

 

Gjelstad S, Høye S, Straand J, Brekke M, Dalen I, Lindbæk M. Improving antibiotic prescribing in acute respiratory tract infections: cluster randomised trial from Norwegian general practice (prescription peer academic detailing (Rx-PAD) study) BMJ. 2013; 347:f4403 [EC,II]

                               R/C

MEJORAR LA PRESCRIPCIÓN DE ANTIBIÓTICOS EN LAS INFECCIONES AGUDAS DE VÍAS RESPIRATORIAS: ENSAYO ALEATORIZADO POR GRUPOS EN LA MEDICINA GENERAL NORUEGA (Rx-PAD)

 

Lawlor DA, Pearce N. The Vienna declaration on nutrition and non-communicable diseases. BMJ. 2013; 347:f4417 [AO,I]

23857985

DECLARACIÓN DE VIENA SOBRE NUTRICIÓN Y ENFERMEDADES NO TRANSMISIBLES

 

Berghöfer A. Lithium and suicide. BMJ. 2013; 347:f4449 [AO,I]

23843554

LITIO Y SUICIDIO

 

Siontis KC, Hernandez-Boussard T, Ioannidis JPA. Overlapping meta-analyses on the same topic: survey of published studies. BMJ. 2013; 347:f4501 [T,I]

                               R/C

METAANÁLISIS SOLAPADO SOBRE EL MISMO TEMA: ENCUESTA DE ESTUDIOS PUBLICADOS

 

Khaw KT. Dietary fats and breast cancer risk. BMJ. 2013; 347:f4518 [AO,I]

23861431

GRASAS EN LA DIETA Y RIESGO DE CÁNCER DE MAMA

 

 

Swanson SA, Colman I. Association between exposure to suicide and suicidality outcomes in youth. CMAJ. 2013; 185:870-877 [S,I]

23695600             R/C

ASOCIACIÓN ENTRE EXPOSICIÓN AL SUICIDIO E INTENTOS EFECTIVOS DE SUICIDIO EN LA JUVENTUD

 

Naqvi R, Liberman D, Rosenberg J, Alston J, Straus S. Preventing cognitive decline in healthy older adults. CMAJ. 2013; 185:881-885 [AO,I]

23589432

PREVENIR EL DETERIORO COGNITIVO EN ANCIANOS SANOS

 

Bird ST, Etminan M, Brophy JM, Hartzema AG, Delaney JA. Risk of acute kidney injury associated with the use of fluoroquinolones. CMAJ. 2013; 185:E475-E482 [S,I]

23734036             R/C

RIESGO DE DAÑO RENAL AGUDO ASOCIADO CON EL USO DE FLUORQUINOLONAS

 

Coldman A, Phillips N. Incidence of breast cancer and estimates of overdiagnosis after the initiation of a population-based mammography screening program. CMAJ. 2013; 185:E492-E498 [T,I]

23754101             R/C

INCIDENCIA DE CÁNCER DE MAMA Y SOBREDIAGNÓSTICO TRAS EL INICIO DE UN PROGRAMA DE CRIBAJE MAMOGRÁFICO POBLACIONAL

 

Egan BM, Li J, Qanungo S, Wolfman TE. Blood pressure and cholesterol control in hypertensive hypercholesterolemic patients: National Health and Nutrition Examination Surveys 1988-2010. Circulation. 2013; 128:29-41 [T,II]

23817481             R/C

CONTROL DE LA PRESIÓN ARTERIAL Y DEL COLESTEROL EN LOS PACIENTES HIPERTENSOS HIPERCOLESTEROLÉMICOS: ENCUESTAS EXAMEN NACIONALES DE SALUD Y NUTRICIÓN 1988-2010

 

Khera AV, Plutzky J. Management of low levels of high-density lipoprotein-cholesterol. Circulation. 2013; 128:72-78 [R,I]

23817482

MANEJO DE LOS NIVELES BAJOS DE COLESTEROL HDL

 

Yong CM, Froelicher V, Wagner G. The electrocardiogram at a crossroads. Circulation. 2013; 128:79-82 [AO,I]

23817483

EL ELECTROCARDIOGRAMA EN LA ENCRUCIJADA

 

Mahfoud F, Ukena C, Schmieder RE, Cremers B, Rump LC, Vonend O, et al. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension. Circulation. 2013; 128:132-140 [QE,II]

23780578             R/C

CAMBIOS EN LA PRESIÓN ARTERIAL AMBULATORIA TRAS DENERVACIÓN SIMPÁTICA RENAL EN PACIENTES CON HIPERTENSIÓN RESISTENTE

 

Zachariah JP. Improving blood pressure in children is protective over the long term. Circulation. 2013; 128:198-199 [AO,I]

23780576

LA MEJORA DE LA PRESIÓN ARTERIAL EN NIÑOS PROTEGE A LARGO PLAZO

 

Verheugt FW. New oral anticoagulants in atrial fibrillation forever? Circulation. 2013; 128:200-202 [AO,I]

23770746

¿NUEVOS ANTICOAGULANTES ORALES EN LA FIBRILACIÓN AURICULAR PARA SIEMPRE?

 

Juhola J, Magnussen CG, Berenson GS, Venn A, Burns TL, Sabin MA, et al. Combined effects of child and adult elevated blood pressure on subclinical atherosclerosis: the International Childhood Cardiovascular Cohort Consortium. Circulation. 2013; 128:217-224 [S,II]

23780579             R/C

EFECTOS COMBINADOS DE LA PRESIÓN ARTERIAL EN NIÑOS Y ADULTOS SOBRE LA ATEROSCLEROSIS SUBCLÍNICA: CONSORCIO INTERNACIONAL COHORTE CARDIOVASCULAR INFANTIL

 

Connolly SJ, Wallentin L, Ezekowitz MD, Eikelboom J, Oldgren J, Reilly PA, et al. The long-term multicenter observational study of dabigatran treatment in patients with atrial fibrillation (RELY-ABLE) study. Circulation. 2013; 128:237-243 [S,II]

23770747             R/C

ESTUDIO OBSERVACIONAL MULTICÉNTRICO DE TRATAMIENTO A LARGO PLAZO CON DABIGATRÁN EN PACIENTES CON FIBRILACIÓN AURICULAR (RELY-ABLE)

 

Parati G, Ochoa JE, Bilo G. Renal sympathetic denervation and daily life blood pressure in resistant hypertension: simplicity or complexity? Circulation. 2013; 128:315-317 [AO,I]

23780577

DENERVACIÓN SIMPÁTICA RENAL Y PRESIÓN ARTERIAL EN LA VIDA DIARIA EN LA HIPERTENSIÓN RESISTENTE: ¿SENCILLEZ O COMPLEJIDAD?

 

Cahill LE, Chiuve SE, Mekary RA, Jensen MK, Flint AJ, Hu FB, et al. Prospective study of breakfast eating and incident coronary heart disease in a cohort of male US health professionals. Circulation. 2013; 128:337-343 [S,I]

23877060             R/C

ESTUDIO PROSPECTIVO DE COMIDA EN EL DESAYUNO E INCIDENCIA DE ENFERMEDAD CARDIACA CORONARIA EN UNA COHORTE DE PROFESIONALES SANITARIOS MASCULINOS DE EE UU

 

Bagai A, Jollis JG, Dauerman HL, Peng SA, Rokos IC, Bates ER, et al. Emergency department bypass for ST-segment-elevation myocardial infarction patients identified with a prehospital electrocardiogram: a report from the American Heart Association Mission: Lifeline Program. Circulation. 2013; 128:352-359 [T,II]

23788525             R/C

PUENTEO DEL DEPARTAMENTO DE URGENCIAS DE PACIENTES CON INFARTO DE MIOCARDIO CON ELEVACIÓN DEL SEGMENTO ST IDENTIFICADOS MEDIANTE ELECTROCARDIOGRAMA PREHOSPITALARIO: INFORME DE LA MISIÓN PROGRAMA VITAL DE LA AHA

 

Magnani JW, Hylek EM, Apovian CM. Obesity begets atrial fibrillation: a contemporary summary. Circulation. 2013; 128:401-405 [AO,I]

23877062

LA OBESIDAD PRODUCE FIBRILACIÓN AURICULAR: RESUMEN CONTEMPORÁNEO

 

Meaney PA, Bobrow BJ, Mancini ME, Christenson J, de Caen AR, Bhanji F, et al; CPR Quality Summit Investigators, the American Heart Association Emergency Cardiovascular Care Committee, and the Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation. Cardiopulmonary resuscitation quality: improving cardiac resuscitation outcomes both inside and outside the hospital: a consensus statement from the American Heart Association. Circulation. 2013; 128:417-435 [M,II]

23801105             R/C

CALIDAD DE LA REANIMACIÓN CARDIOPULMONAR: MEJORAR LOS RESULTADOS DE LA REANIMACIÓN CARDIOPUMONAR TANTO DENTRO COMO FUERA DEL HOSPITAL: DECLARACIÓN DE CONSENSO DE LA AHA

 

Cefalu WT, Rosenstock J, Henry RR, Riddle M. Signals and noise in drug safety analyses: the incretin therapy debate provides the rationale for revamping epidemiologic pharmacovigilance. Diabetes Care. 2013; 36:1804-1806 [AO,I]

23695816

SEÑALES Y RUIDO EN LOS ANÁLISIS DE SEGURIDAD DE FÁRMACOS: EL DEBATE SOBRE EL TRATAMIENTO CON INCRETINAS PROPORCIONA RACIONALIDAD PARA PONER AL DÍA LA FARMACOVIGILANCIA EPIDEMIOLÓGICA

 

Draznin B, Gilden J, Golden SH, Inzucchi SE; PRIDE investigators. Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action. Diabetes Care. 2013; 36:1807-1814 [AO,II]

23801791             R/C

RUTAS HACIA EL TRATAMIENTO HOSPITALARIO DE CALIDAD DE LA HIPERGLUCEMIA Y LA DIABETES: LLAMAMIENTO A LA ACCIÓN

 

Myers VH, McVay MA, Brashear MM, Johannsen NM, Swift DL, Kramer K, et al. Exercise training and quality of life in individuals with type 2 diabetes: a randomized controlled trial. Diabetes Care. 2013; 36:1884-1890 [EC,I]

23404304             R/C

ENTRENAMIENTO FÍSICO Y CALIDAD DE VIDA EN LOS INDIVIDUOS CON DIABETES TIPO 2: ENSAYO ALEATORIZADO CONTROLADO

 

Chatterjee R, Narayan KM, Lipscomb J, Jackson SL, Long Q, Zhu M, et al. Screening for diabetes and prediabetes should be cost-saving in patients at high risk. Diabetes Care. 2013; 36:1981-1987 [CE,II]

23393215             R/C

EL CRIBAJE DE LA DIABETES Y LA PREDIABETES DEBERÍA AHORRAR COSTES EN LOS PACIENTES DE ALTO RIESGO

 

Zhu WW, Fan L, Yang HX, Kong LY, Su SP, Wang ZL, et al. Fasting plasma glucose at 24-28 weeks to screen for gestational diabetes mellitus: new evidence from China. Diabetes Care. 2013; 36:2038-2040 [T,I]

23536582             R/C

GLUCOSA PLASMÁTICA EN AYUNAS A LAS 24-28 SEMANAS PARA CRIBAR LA DIABETES MELLITUS GESTACIONAL: NUEVAS PRUEBAS DESDE CHINA

 

Butler PC, Elashoff M, Elashoff R, Gale EA. A critical analysis of the clinical use of incretin-based therapies: are the GLP-1 therapies safe? Diabetes Care. 2013; 36:2118-2125 [R,II]

23645885             R/C

ANÁLISIS CRÍTICO DEL USO DE TRATAMIENTOS BASADOS EN INCRETINAS: ¿SON SEGUROS LOS TRATAMIENTOS CON GLP-1?

 

Nauck MA. A critical analysis of the clinical use of incretin-based therapies: the benefits by far outweigh the potential risks. Diabetes Care. 2013; 36:2126-2132 [R,II]

23645884             R/C

ANÁLISIS CRÍTICO DEL USO DE TRATAMIENTOS BASADOS EN INCRETINAS: LOS BENEFICIOS HASTA EL MOMENTO SUPERAN A LOS RIESGOS POTENCIALES

 

Brass EP. Intermittent claudication: new targets for drug development. Drugs. 2013; 73:999-1014 [AO,I]

23775528             R/C

CLAUDICACIÓN INTERMITENTE: NUEVAS DIANAS PARA EL DESARROLO DE FÁRMACOS

 

Orme IM. Vaccine development for tuberculosis: current progress. Drugs. 2013; 73:1015-1024 [R,I]

23794129             R/C

DESARROLLO DE VACUNAS PARA LA TUBERCULOSIS: PROGRESO ACTUAL

 

Alla VM, Agrawal V, Denazareth A, Mohiuddin S, Ravilla S, Rendell M. A reappraisal of the risks and benefits of treating to target with cholesterol lowering drugs. Drugs. 2013; 73:1025-1054 [R,II]

23754124             R/C

REEVALUACIÓN DE LOS RIESGOS Y BENEFICIOS DE TRATAR POR OBJETIVOS CON LOS FÁRMACOS REDUCTORES DEL COLESTEROL

 

Torta RG, Ieraci V. Pharmacological management of depression in patients with cancer: practical considerations. Drugs. 2013; 73:1131-1145 [R,I]

23839658             R/C

TRATAMIENTO FARMACOLÓGICO DE LA DEPRESIÓN EN PACIENTES CON CÁNCER: CONSIDERACIONES PRÁCTICAS

 

Cohn AC, Harrison LH. Meningococcal vaccines: current issues and future strategies. Drugs. 2013; 73:1147-1155 [R,I]

23839656             R/C

VACUNAS MENINGOCÓCICAS: ASPECTOS ACTUALES Y ESTRATEGIAS FUTURAS

 

Sardar P, Chatterjee S, Mukherjee D. Efficacy and safety of new oral anticoagulants for extended treatment of venous thromboembolism: systematic review and meta-analyses of randomized controlled trials. Drugs. 2013; 73:1171-1182 [M,II]

23812923             R/C

EFICACIA Y SEGURIDAD DE LOS NUEVOS ANTICOAGULANTES ORALES EN EL TRATAMIENTO AMPLIADO DEL TROMBOEMBOLISMO VENOSO: REVISIÓN SISTEMÁTICA Y METAANÁLISIS DE ENSAYOS ALEATORIZADOS CONTROLADOS

 

Vlachopoulos C, Jackson G, Stefanadis C, Montorsi P. Erectile dysfunction in the cardiovascular patient. Eur Heart J. 2013; 34:2034-2046 [R,I]

23616415             R/C

DISFUNCIÓN ERÉCTIL EN EL PACIENTE CARDIOVASCULAR

 

Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J, et al. EHRA Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary. Eur Heart J. 2013; 34:2094-2106 [M,III]

23625209

GUÍA PRÁCTICA EHRA SOBRE USO DE LOS NUEVOS ANTICOAGULANTES ORALES EN PACIENTES CON FIBRILACIÓN AURICULAR NO VALVULAR

 

Mahfoud F, Lüscher TF, Andersson B, Baumgartner I, Cifkova R, Dimario C, et al. Expert consensus document from the European Society of Cardiology on catheter-based renal denervation. Eur Heart J. 2013; 34:2149-2157 [M,II]

23620497

DOCUMENTO DE CONSENSO DE EXPERTOS DE LA ESC SOBRE DENERVACIÓN RENAL MEDIANTE CATÉTER

 

Authors/Task Force Members, Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al; ESC Committee for Practice Guidelines (CPG), Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, et al; Document Reviewers, Clement DL, Coca A, Gillebert TC, Tendera M, Rosei EA, Ambrosioni E, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013; 34:2159-2219 [M,III]

23771844

PAUTAS DE 2013 DE LA ESH/ESC PARA EL MANEJO DE LA HIPERTENSIÓN ARTERIAL: GRUPO DE TRABAJO PARA EL MANEJO DE LA HIPERTENSIÓN ARTERIAL DE LA ESH Y LA ESC

 

 

Klabunde CN, Han PK, Earle CC, Smith T, Ayanian JZ, Lee R, et al. Physician roles in the cancer-related follow-up care of cancer survivors. Fam Med. 2013; 45:463-474 [T,I]

23846965             R/C

PAPEL DEL MÉDICO EN LA ATENCIÓN DE SEGUIMIENTO RELACIONADA CON EL CÁNCER EN LOS SUPERVIVIENTES DE CÁNCER

Kruse RL, Olsberg JE, Shigaki CL, Parker Oliver DR, Vetter-Smith MJ, Day TM, et al. Communication during patient-provider encounters regarding diabetes self-management. Fam Med. 2013; 45:475-483 [C,I]

23846966             R/C

COMUNICACIÓN EN LOS ENCUENTROS ENTRE EL PACIENTE Y EL PROFESIONAL RESPECTO AL AUTOMANEJO DE LA DIABETES

Heidelbaugh J, Cooke J, Wimsatt L. Opportunities for medical student engagement with family medicine. Fam Med. 2013; 45:484-491 [T,I]

23846967             R/C

OPORTUNIDADES PARA EL COMPROMISO DEL ESTUDIANTE DE MEDICINA CON LA MEDICINA DE FAMILIA

Cass AR, Alonso WJ, Islam J, Weller SC. Risk of obstructive sleep apnea in patients with type 2 diabetes mellitus. Fam Med. 2013; 45:492-500 [T,I]

23846968             R/C

RIESGO DE APNEA OBSTRUCTIVA DEL SUEÑO EN PACIENTES CON DIABETES MELLITUS TIPO 2

 

Morgan A. Beneficios y retos de la salud pública basada en la evidencia: la experiencia del National Institute for Health and Care Excellence. Gac Sanit. 2013; 27:287-289 [AO,I]

23759186

BENEFICIOS Y RETOS DE LA SALUD PÚBLICA BASADA EN LA EVIDENCIA: LA EXPERIENCIA DEL NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

 

Murillo C, Saurina C. Medida de la importancia de las dimensiones de la satisfacción en la provisión de servicios de salud. Gac Sanit. 2013; 27:304-309 [T,I]

23416027             R/C

MEDIDA DE LA IMPORTANCIA DE LAS DIMENSIONES DE LA SATISFACCIÓN EN LA PROVISIÓN DE SERVICIOS DE SALUD

 

Nuño-Solinis R, Rodríguez-Pereira C, Piñera-Elorriaga K, Zaballa-González I, Bikandi-Irazabal J. Panorama de las iniciativas de educación para el autocuidado en España. Gac Sanit. 2013; 27:332-337 [T,I]

23465729             R/C

PANORAMA DE LAS INICIATIVAS DE EDUCACIÓN PARA EL AUTOCUIDADO EN ESPAÑA

 

Guitard ML, Torres J, Farreny D, Gutiérrez JM, Martínez M, Artigues EM. Cumplimiento de las recomendaciones sobre actividad física en personas hipertensas asistidas en atención primaria. Gac Sanit. 2013; 27:365-368 [T,I]

23287102             R/C

CUMPLIMIENTO DE LAS RECOMENDACIONES SOBRE ACTIVIDAD FÍSICA EN PERSONAS HIPERTENSAS ASISTIDAS EN ATENCIÓN PRIMARIA

 

Gérvas J, Pérez Fernández M. Cribados: una propuesta de racionalización. Gac Sanit. 2013; 27:372-373 [AO,I]

23669503             R/C

CRIBADOS: UNA PROPUESTA DE RACIONALIZACIÓN

 

 

Pearson WS, King DE, Richards C. Capitated payments to primary care providers and the delivery of patient education. J Am Board Fam Med. 2013; 26:350-355 [T,I]

23833148             R/C

PAGO POR CAPITACIÓN DE LOS PROFESIONALES DE ATENCIÓN PRIMARIA Y SUMINISTRO DE EDUCACIÓN SANITARIA

 

Mittelstaedt TS, Mori M, Lambert WE, Saultz JW. Provider practice characteristics that promote interpersonal continuity. J Am Board Fam Med. 2013; 26:356-365 [C,T,I]

23833149             R/C

CARACTERÍSTICAS DE LA PRÁCTICA PROFESIONAL QUE PROMUEVEN LA CONTINUIDAD INTERPERSONAL

 

Li J, Berkowitz Z, Richards TB, Richardson LC. Shared decision making in prostate-specific antigen testing with men older than 70 years. J Am Board Fam Med. 2013; 26:401-408 [T,I]

23833155             R/C

TOMA DE DECISIONES COMPARTIDAS EN LA PRÁCTICA DEL PSA EN HOMBRES MAYORES DE 70 AÑOS

 

Hayon R, Dalby J, Paddock E, Combs M, Schrager S. Reproductive health care of adolescent women. J Am Board Fam Med. 2013; 26:460-469 [R,II]

23833162             R/C

ATENCIÓN SANITARIA REPRODUCTIVA DE LAS ADOLESCENTES

 

Nakawah MO, Hawkins C, Barbandi F. Asthma, chronic obstructive pulmonary disease (COPD), and the overlap syndrome. J Am Board Fam Med. 2013; 26:470-477 [R,I]

23833163             R/C

ASMA, EPOC Y SÍNDROME DE SOLAPAMIENTO

 

 

Cedars MI. In vitro fertilization and risk of autistic disorder and mental retardation. JAMA. 2013; 310:42-43 [AO,I]

23821086

FERTILIZACIÓN IN VITRO Y RIESGO DE TRASTORNO AUTISTA Y RETRASO MENTAL

 

Hernandez AF. Preventing heart failure. JAMA. 2013; 310:44-45 [AO,I]

23821087

PREVENIR LA INSUFICIENCIA CARDIACA

 

Lindson-Hawley N, Aveyard P, Hughes JR. Gradual reduction vs abrupt cessation as a smoking cessation strategy in smokers who want to quit. JAMA. 2013; 310:91-92 [AO,I]

23821093             R/C

REDUCCIÓN GRADUAL O CESE ABRUPTO COMO ESTRATEGIA DE ABANDONO TABÁQUICO EN FUMADORES QUE QUIEREN HACERLO

 

Brilakis ES, Patel VG, Banerjee S. Medical management after coronary stent implantation: a review. JAMA. 2013; 310:189-198 [R,I]

23839753             R/C

TRATAMIENTO MÉDICO TRAS LA IMPLANTACIÓN DE ESTENT CORONARIO: REVISIÓN

 

Emanuel EJ, Steinmetz A. Will physicians lead on controlling health care costs? JAMA. 2013; 310:374-375 [AO,I]

23917285

¿VAN A LIDERAR LOS MÉDICOS EL CONTROL DE LOS COSTES DE LA ATENCIÓN SANITARIA?

 

Tilburt JC, Wynia MK, Sheeler RD, Thorsteinsdottir B, James KM, Egginton JS, et al. Views of US physicians about controlling health care costs. JAMA. 2013; 310:380-388 [T,I]

23917288             R/C

PUNTOS DE VISTA DE LOS MÉDICOS ESTADOUNIDENSES SOBRE EL CONTROL DE LOS COSTES DE LA ATENCIÓN SANITARIA

 

Ferraro PM, Taylor EN, Eisner BH, Gambaro G, Rimm EB, Mukamal KJ, et al. History of kidney stones and the risk of coronary heart disease. JAMA. 2013; 310:408-415 [S,I]

23917291             R/C

HISTORIA DE LOS CÁLCULOS RENALES Y RIESGO DE ENFERMEDAD CARDIACA CORONARIA

Mrkobrada M, Hackam DG. Selective serotonin reuptake inhibitors and surgery: to hold or not to hold, that is the question: comment on "perioperative use of selective serotonin reuptake inhibitors and risks for adverse outcomes of surgery". JAMA Intern Med. 2013; 173:1082-1083 [AO,I]

23699775

ISRS Y CIRUGÍA: MANTENER O NO MANTENER, ÉSA ES LA CUESTIÓN: COMENTARIO SOBRE "USO PERIOPERATORIO DE LOS ISRS Y RIESGOS DE RESULTADOS ADVERSOS DE LA CIRUGÍA"

 

Gershon A, Croxford R, Calzavara A, To T, Stanbrook MB, Upshur R, et al. Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease. JAMA Intern Med. 2013; 173:1175-1185 [CC,II]

23689820             R/C

SEGURIDAD CARDIOVASCULAR DE LOS LABA INHALADOS EN INDIVIDUOS CON EPOC

 

Woodruff PG. Double-edged sword?: long-acting bronchodilators in chronic obstructive pulmonary disease. JAMA Intern Med. 2013; 173:1184-1185 [AO,I]

23689337

¿ESPADA DE DOBLE FILO?: LABA EN LA EPOC

 

Lipkin M. Shared decision making. JAMA Intern Med. 2013; 173:1204-1205 [AO,I]

23712307

TOMA DE DECISIONES COMPARTIDA

 

Fowler FJ, Gerstein BS, Barry MJ. How patient centered are medical decisions?: results of a national survey. JAMA Intern Med. 2013; 173:1215-1221 [T,I]

23712194             R/C

¿CÓMO DE CENTRADAS EN EL PACIENTE ESTÁN LAS DECISIONES MÉDICAS?: RESULTADOS DE UNA ENCUESTA NACIONAL

 

Baron RB. Should we all be vegetarians? JAMA Intern Med. 2013; 173:1238-1239 [AO,I]

23836265

¿DEBERÍAMOS SER TODOS VEGETARIANOS?

 

Lipitz-Snyderman A, Bach PB. Overuse of health care services: when less is more … more or less. JAMA Intern Med. 2013; 173:1277-1278 [AO,I]

23712254

USO EXCESIVO DE LOS SERVICIOS DE ATENCIÓN SANITARIA: CUANDO MENOS ES MÁS (MÁS O MENOS)

 

Ioannidis JP, Prasad V. Evaluating health system processes with randomized controlled trials. JAMA Intern Med. 2013; 173:1279-1280 [AO,I]

23689271

EVALUAR LOS PROCESOS DEL SISTEMA SANITARIO MEDIANTE ENSAYOS ALEATORIZADOS CONTROLADOS

 

Jacobson MF, Havas S, McCarter R. Changes in sodium levels in processed and restaurant foods, 2005 to 2011. JAMA Intern Med. 2013; 173:1285-1291 [T,I]

23699927             R/C

CAMBIOS EN LOS NIVELES DE SODIO EN LAS COMIDAS PROCESADAS Y DE LOS RESTAURANTES, 2005 A 2011

 

Urban LE, Lichtenstein AH, Gary CE, Fierstein JL, Equi A, Kussmaul C, et al. The energy content of restaurant foods without stated calorie information. JAMA Intern Med. 2013; 173:1292-1299 [T,I]

23700076             R/C

CONTENIDO ENERGÉTICO DE LAS COMIDAS DE LOS RESTAURANTES SIN INFORMACIÓN EXPLÍCITA DE LAS CALORÍAS

Lipska KJ, Montori VM. Glucose control in older adults with diabetes mellitus-more harm than good? JAMA Intern Med. 2013; 173:1306-1307 [AO,I]

23753259

CONTROL DE GLUCOSA EN ANCIANOS CON DIABETES MELLITUS ¿MÁS PERJUICIO QUE BENEFICIO?

 

Mansi I, Frei CR, Pugh MJ, Makris U, Mortensen EM. Statins and musculoskeletal conditions, arthropathies, and injuries. JAMA Intern Med. 2013; 173:1318-1326 [S,II]

23877079             R/C

ESTATINAS Y ENFERMEDADES OSTEOMUSCULARES, ARTROPATÍAS Y HERIDAS

 

Pan A, Sun Q, Bernstein AM, Manson JE, Willett WC, Hu FB. Changes in red meat consumption and subsequent risk of type 2 diabetes mellitus: three cohorts of US men and women. JAMA Intern Med. 2013; 173:1328-1335 [S,II]

23779232             R/C

CAMBIOS EN EL CONSUMO DE CARNE ROJA Y RIESGO SUBSIGUIENTE DE DIABETES MELLITUS TIPO 2: TRES COHORTES DE MUJERES Y HOMBRES ESTADOUNIDENSES

 

Parboosing R, Bao Y, Shen L, Schaefer CA, Brown AS. Gestational influenza and bipolar disorder in adult offspring. JAMA Psychiatry. 2013; 70:677-685 [CC,I]

23699867             R/C

GRIPE EN EL EMBARAZO Y TRASTORNO BIPOLAR EN LA DESCENDENCIA

Ilgen MA, Kleinberg F, Ignacio RV, Bohnert AS, Valenstein M, McCarthy JF, et al. Noncancer pain conditions and risk of suicide. JAMA Psychiatry. 2013; 70:692-697 [T,I]

23699975             R/C

TRASTORNOS DOLOROSOS NO ONCOLÓGICOS Y RIESGO DE SUICIDIO

 

Evangelista L, Juncadella E, Copetti S, Pareja A, Torrabadella J, Evangelista A. Utilidad diagnóstica de la ecografía de bolsillo practicada por un médico de familia en una población hipertensa. Med Clin (Barc). 2013; 141:1-7 [T,I]

23453921             R/C

UTILIDAD DIAGNÓSTICA DE LA ECOGRAFÍA DE BOLSILLO PRACTICADA POR UN MÉDICO DE FAMILIA EN UNA POBLACIÓN HIPERTENSA

 

Ascunce N, Delfrade J, Salas D, Zubizarreta R, Ederra M; en nombre de Red de Programas de Cribado de Cáncer. Programas de detección precoz de cáncer de mama en España: características y principales resultados. Med Clin (Barc). 2013; 141:13-23 [T,II]

22704275             R/C

PROGRAMAS DE DETECCIÓN PRECOZ DE CÁNCER DE MAMA EN ESPAÑA: CARACTERÍSTICAS Y PRINCIPALES RESULTADOS

 

González-Juanatey JR, Abu-Assi E. Ecografía de bolsillo practicada por un médico de familia: democratización sí, revolución no. Med Clin (Barc). 2013; 141:24-26 [AO,I]

23452671

ECOGRAFÍA DE BOLSILLO PRACTICADA POR UN MÉDICO DE FAMILIA: DEMOCRATIZACIÓN SÍ, REVOLUCIÓN NO

 

Ruilope LM, Arribas F. Hipertensión arterial resistente: de la prevención a la denervación renal. Med Clin (Barc). 2013; 141:27-28 [AO,I]

23337447

HIPERTENSIÓN ARTERIAL RESISTENTE: DE LA PREVENCIÓN A LA DENERVACIÓN RENAL

 

Garcia-Ruiz PJ. Aplicaciones de la toxina botulínica en Neurología. Med Clin (Barc). 2013; 141:33-36 [AO,I]

23434466

APLICACIONES DE LA TOXINA BOTULÍNICA EN NEUROLOGÍA

 

Sicras A, Muñoz G, Font B, Majós N, Navarro R, Ibáñez J. Relación entre la polimedicación y el control de la presión arterial: cumplimiento, persistencia, costes e incidencia de nuevos eventos cardiovasculares. Med Clin (Barc). 2013; 141:53-61 [T,I]

22766057             R/C

RELACIÓN ENTRE LA POLIMEDICACIÓN Y EL CONTROL DE LA PRESIÓN ARTERIAL: CUMPLIMIENTO, PERSISTENCIA, COSTES E INCIDENCIA DE NUEVOS EVENTOS CARDIOVASCULARES

 

Trilla A. Seguridad y efectividad de la vacuna antigripal: nuevos datos, nuevos retos. Med Clin (Barc). 2013; 141:67-69 [AO,I]

23768850

SEGURIDAD Y EFECTIVIDAD DE LA VACUNA ANTIGRIPAL: NUEVOS DATOS, NUEVOS RETOS

 

Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion. U.S. Selected practice recommendations for contraceptive use, 2013: adapted from the World Health Organization selected practice recommendations for contraceptive use, 2nd edition. MMWR Recomm Rep. 2013; 62:1-60 [M,III]

23784109             R/C

RECOMENDACIONES PRÁCTICAS SELECCIONADAS EN EL USO DE ANTICONCEPTIVOS EN EE UU PARA 2013: ADAPTADAS DE LAS RECOMENDACIONES PRÁCTICAS SELECCIONADAS POR LA OMS EN EL USO DE ANTICONCEPTIVOS, 2ª EDICIÓN

 

 

Arias MA, Baranchuk A. Fibrilación auricular y apnea obstructiva del sueño: algo más que una coincidencia. Rev Esp Cardiol. 2013; 66:529-531 [AO,I]

23711362

FIBRILACIÓN AURICULAR Y APNEA OBSTRUCTIVA DEL SUEÑO: ALGO MÁS QUE UNA COINCIDENCIA

 

Clua-Espuny JL, Lechuga-Duran I, Bosch-Princep R, Roso-Llorach A, Panisello-Tafalla A, Lucas-Noll J, et al. Prevalencia de la fibrilación auricular desconocida y la no tratada con anticoagulantes. Estudio AFABE. Rev Esp Cardiol. 2013; 66:545-552  [T,I]

23727072             R/C

PREVALENCIA DE LA FIBRILACIÓN AURICULAR DESCONOCIDA Y LA NO TRATADA CON ANTICOAGULANTES. ESTUDIO AFABE

 

Pérez-Villacastín J, Pérez N, Moreno J. Epidemiología de la fibrilación auricular en España en los últimos 20 años. Rev Esp Cardiol. 2013; 66:561-565 [T,II]

23721937             R/C

EPIDEMIOLOGÍA DE LA FIBRILACIÓN AURICULAR EN ESPAÑA EN LOS ÚLTIMOS 20 AÑOS

 

Stewart R. Reducing depression in nursing homes: so little, so late. Lancet. 2013; 381:2227-2228 [AO,I]

23643108

REDUCIR LA DEPRESIÓN EN LAS RESIDENCIAS: TAN POCO, TAN TARDE

 

Steffens DC. Exercise for late-life depression? It depends. Lancet. 2013; 382:4-5 [AO,I]

23643109

¿EJERCICIO PARA LA DEPRESIÓN EN LA EDAD AVANZADA? DEPENDE

 

Eastell R, Walsh JS. Is it time to combine osteoporosis therapies? Lancet. 2013; 382:5-7 [AO,I]

23683601

¿ES HORA DE COMBINAR LOS TRATAMIENTOS PARA LA OSTEOPOROSIS?

 

Underwood M, Lamb SE, Eldridge S, Sheehan B, Slowther AM, Spencer A, et al. Exercise for depression in elderly residents of care homes: a cluster-randomised controlled trial. Lancet. 2013; 382:41-49 [EC,II]

23643112             R/C

EJERCICIO PARA LA DEPRESIÓN EN LOS ANCIANOS DE LAS RESIDENCIAS: ENSAYO COBNTROLADO ALEATORIZADO POR GRUPOS

 

Tsai JN, Uihlein AV, Lee H, Kumbhani R, Siwila-Sackman E, McKay EA, et al. Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial. Lancet. 2013; 382:50-56 [EC,I]

23683600             R/C

TERIPARATIDA Y DENOSUMAB, SOLOS O COMBINADOS, EN MUJERES CON OSTEOPOROSIS POSTMENOPÁUSICA: ESTUDIO ALEATORIZADO DATA

 

The global issue of kidney disease. Lancet. 2013; 382:101 [AO,I]

23849909

LA CUESTIÓN MUNDIAL DE LA ENFERMEDAD RENAL

 

Eckardt KU, Coresh J, Devuyst O, Johnson RJ, Köttgen A, Levey AS, et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet. 2013; 382:158-169 [R,I]

23727165             R/C

IMPORTANCIA EN AUMENTO DE LA ENFERMEDAD RENAL: DE SUBESPECIALIDAD A CARGA MUNDIAL DE SALUD

 

Lameire NH, Bagga A, Cruz D, De Maeseneer J, Endre Z, Kellum JA, et al. Acute kidney injury: an increasing global concern. Lancet. 2013; 382:170-179 [R,I]

23727171             R/C

DAÑO RENAL AGUDO: PREOCUPACIÓN MUNDIAL EN AUMENTO

 

Tobacco control: when economics trumps health. Lancet. 2013; 382:182 [AO,I]

23870519

CONTROL DEL TABACO: CUANDO LA ECONOMÍA SUPERA A LA SALUD

 

Campion J, Bhugra D, Bailey S, Marmot M. Inequality and mental disorders: opportunities for action. Lancet. 2013; 382:183-184 [AO,I]

23870520

DESIGUALDAD Y TRASTORNOS MENTALES: OPORTUNIDADES PARA LA ACTUACIÓN

 

Natchu UC, Bhatnagar S. Diarrhoea in children: identifying the cause and burden. Lancet. 2013; 382:184-186 [AO,I]

23680351

DIARREA EN LOS NIÑOS: IDENTIFICAR LA CAUSA Y LA CARGA

 

Jewkes R. Intimate partner violence: the end of routine screening. Lancet. 2013; 382:190-191 [AO,I]

23598182

VIOLENCIA DE PAREJA: EL FIN DEL CRIBAJE RUTINARIO

 

Hegarty K, O'Doherty L, Taft A, Chondros P, Brown S, Valpied J, et al. Screening and counselling in the primary care setting for women who have experienced intimate partner violence (WEAVE): a cluster randomised controlled trial. Lancet. 2013; 382:249-258 [EC,II]

23598181             R/C

CRIBAJE Y CONSEJO EN LOS DISPOSITIVOS DE ATENCIÓN PRIMARIA PARA LAS MUJERES QUE HAN EXPERIMENTADO VIOLENCIA DE PAREJA (WEAVE): ENSAYO CONTROLADO ALEATORIZADO POR GRUPOS

 

Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013; 382:260-272 [R,I]

23727169             R/C

ENFERMEDAD RENAL CRÓNICA: DIMENSIÓN Y PERSPECTIVAS MUNDIALES

 

Stagnaro-Green A, Pearce EN. Iodine and pregnancy: a call to action. Lancet. 2013; 382:292-293 [AO,I]

23706509

IODO Y EMBARAZO: LLAMAMIENTO A LA ACCIÓN

 

Bath SC, Steer CD, Golding J, Emmett P, Rayman MP. Effect of inadequate iodine status in UK pregnant women on cognitive outcomes in their children: results from the Avon Longitudinal Study of Parents and Children (ALSPAC). Lancet. 2013; 382:331-337 [S,II]

23706508             R/C

EFECTO DEL ESTATUS INADECUADO DE IODO EN MUJERES EMBARAZADAS EN RU SOBRE LOS RESULTADOS COGNITIVOS DE SUS NIÑOS: RESULTADOS DEL ESTUDIO ALSPAC

 

Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013; 382:339-352 [R,II]

23727170             R/C

ENFERMEDAD RENAL CRÓNICA Y RIESGO CARDIOVASCULAR: EPIDEMIOLOGÍA, MECANISMOS Y PREVENCIÓN

 

Remuzzi G, Benigni A, Finkelstein FO, Grunfeld JP, Joly D, Katz I, et al. Kidney failure: aims for the next 10 years and barriers to success. Lancet. 2013; 382:353-362 [R,II]

23727164             R/C

INSUFICIENCIA RENAL: PROPÓSITOS PARA LOS PRÓXIMOS 10 AÑOS Y BARRERAS PARA EL ÉXITO

 

Black N. Can England's NHS survive? N Engl J Med. 2013; 369:1-3 [AO,I]

23782160

¿PUEDE SOBREVIVIR EL NHS INGLÉS?

 

Wang Y, Wang Y, Zhao X, Liu L, Wang D, Wang C, et al; CHANCE Investigators. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013; 369:11-19 [EC,I]

23803136             R/C

CLOPIDOGREL CON ASPIRINA EN EL ICTUS LEVE O EL AIT

 

Becker AE, Kleinman A. Mental health and the global agenda. N Engl J Med. 2013; 369:66-73 [AO,II]

23822778

SALUD MENTAL Y PLANIFICACIÓN MUNDIAL

 

Hankey GJ. Dual antiplatelet therapy in acute transient ischemic attack and minor stroke. N Engl J Med. 2013; 369:82-83 [AO,I]

23803138

TRATAMIENTO DOBLE ANTIPLAQUETARIO EN EL AIT Y EL ICTUS LEVE

 

Griffin MR, Zhu Y, Moore MR, Whitney CG, Grijalva CG. U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination. N Engl J Med. 2013; 369:155-163 [T,II]

23841730             R/C

HOSPITALIZACIONES POR NEUMONÍA EN LOS EE UU TRAS UNA DÉCADA DE VACUNACIÓN NEUMOCÓCICA

 

Baggett TP, Tobey ML, Rigotti NA. Tobacco use among homeless people--addressing the neglected addiction. N Engl J Med. 2013; 369:201-204 [AO,I]

23863048

USO DEL TABACO ENTRE LA POBLACIÓN INDIGENTE--ABORDAR UNA ADICCIÓN OLVIDADA

 

Cohen JI. Clinical practice: Herpes zoster. N Engl J Med. 2013; 369:255-263 [R,I]

23863052

PRÁCTICA CLÍNICA: HERPES ZOSTER

 

Morden NE, Schwartz LM, Fisher ES, Woloshin S. Accountable prescribing. N Engl J Med. 2013; 369:299-302 [AO,I]

23883375

PRESCRIPCIÓN RESPONSABLE

 

Cryer PE. Mechanisms of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med. 2013; 369:362-372 [R,I]

23883381

MECANISMOS DE FALLO AUTONÓMICO ASOCIADO A HIPOGLUCEMIA

 

 

Jenkins G. Pirfenidone should be prescribed for patients with idiopathic pulmonary fibrosis. Thorax. 2013; 68:603-605 [AO,I]

23462153

LA PIRFENIDONA SE DEBERÍA PRESCRIBIR A PACIENTES CON FIBROSIS PULMONAR IDIOPÁTICA

 

Raghu G, Thickett DR. Pirfenidone for IPF: pro/con debate; the 'con' viewpoint. Thorax. 2013; 68:605-608 [AO,I]

23462155

PIRFENIDONA EN LA FIBROSIS PULMONAR IDIOPÁTICA: DEBATES DE PROS Y CONTRAS; EL PUNTO DE VISTA EN CONTRA

 

Kupczyk M, Haque S, Sterk PJ, Nizankowska-Mogilnicka E, Papi A, Bel EH, et al; BIOAIR investigators. Detection of exacerbations in asthma based on electronic diary data: results from the 1-year prospective BIOAIR study. Thorax. 2013; 68:611-618 [S,II]

23564399             R/C

DETECCIÓN DE LAS EXACERBACIONES DEL ASMA BASADA EN LOS DATOS DE DIARIO ELECTRÓNICO: RESULTADOS DE 1 AÑO DEL ESTUDIO PROSPECTIVO BIOAIR

 

Sims M, Maxwell R, Gilmore A. Short-term impact of the smokefree legislation in England on emergency hospital admissions for asthma among adults: a population-based study. Thorax. 2013; 68:619-624 [S,I]

23589509             R/C

IMPACTO A CORTO PLAZO DE LA LEGISLACIÓN LIBRE DE HUMO EN INGLATERRA SOBRE LOS INGRESOS DE URGENCIA HOSPITALARIOS POR ASMA EN ADULTOS: ESTUDIO POBLACIONAL

 

ANALS OF INTERNAL MEDICINE

 

S23817703

Moderate-strength evidence shows that healing of pressure ulcers in adults is improved with the use of air-fluidized beds, protein supplementation, radiant heat dressings, and electrical stimulation.

S23712349

The OGCT and fasting plasma glucose level (at a threshold of 4.7 mmol/L [85 mg/dL]) by 24 weeks' gestation are good at identifying women who do not have GDM. The OGCT is better at identifying women who have GDM. The OGCT has not been validated for the IADPSG diagnostic criteria.

S23712381

Treating GDM results in less preeclampsia, shoulder dystocia, and macrosomia; however, current evidence does not show an effect on neonatal hypoglycemia or future poor metabolic outcomes. There is little evidence of short-term harm of treating GDM other than an increased demand for services.

S23856681

Long-term use of alternate-day, low-dose aspirin may reduce risk for colorectal cancer in healthy women.

S23817702

More advanced static support surfaces are more effective than standard mattresses for preventing ulcers in higher-risk populations. The effectiveness of formal risk assessment instruments and associated intervention protocols compared with less standardized assessment methods and the effectiveness of other preventive interventions compared with usual care have not been clearly established.

 

ARTHRITIS AND RHEUMATISM

 

S23529645

Our findings indicate altered meniscal position and shape (i.e., more bulging) in both compartments in medial compartment knee OA. These changes may be important features of OA pathogenesis and/or disease consequences.

S23553508

QST measures and the PD-Q identified features of neuropathic pain in subjects in this community-based study, with significant overlap between the findings of the two techniques.

S23553790

Our findings indicate that tanezumab provides superior pain relief and improvement in physical function and patient's global assessment versus placebo in patients with painful hip OA, and is generally well tolerated.

 

BRITISH JOURNAL OF PSYCHIATRY

 

S23818534

Lower educational attainment in women was associated with an increased risk of dementia-related death independently of common risk behaviours and comorbidities.

 

BRITISH MEDICAL JOURNAL

 

S23833075

There was a small increase in the incidence of mental disorders in children born after ovulation induction/intrauterine insemination. Children born after in vitro fertilisation/intracytoplasmic sperm injection were found to have overall risk comparable with children conceived spontaneously.

 

Conclusions the intervention led to improved antibiotic prescribing for respiratory tract infections in a representative sample of Norwegian general practitioners, and the courses were feasible to the general practitioners.

 

While some independent replication of meta-analyses by different teams is possibly useful, the overall picture suggests that there is a waste of efforts with many topics covered by multiple overlapping meta-analyses

S23819963

Most patients in this survey seemed favorable to the idea of placebo treatments and valued honesty and transparency in this context, suggesting that physicians should consider engaging with patients to discuss their values and attitudes about the appropriateness of using treatments aimed at promoting placebo responses in the context of clinical decision making.

S23873919

Tdap vaccination was moderately effective at preventing PCR confirmed pertussis among adolescents and adults.

S23874437

The present study provides evidence of a relationship between dietary patterns, fish intake or n-3 PUFA intake from seafood and symptoms of anxiety in pregnancy, and suggests that dietary interventions could be used to reduce high anxiety symptoms during pregnancy.

 

CANADIAN MEDICAL ASSOCIATION JOURNAL

 

S23734036

We found a small, but significant, increased risk of acute kidney injury among men with the use of oral fluoroquinolones, as well as a significant interaction between the concomitant use of fluoroquinolones and renin-angiotensin-system blockers.

S23754101

The extent of overdiagnosis of invasive cancer in our study population was modest and primarily occurred among women over the age of 60 years. However, overdiagnosis of ductal carcinoma in situ was elevated for all age groups. The estimation of overdiagnosis from observational data is complex and subject to many influences. The use of mammography screening in older women has an increased risk of overdiagnosis, which should be considered in screening decisions.

S23695600

We found that exposure to suicide predicts suicide ideation and attempts. Our results support school-wide interventions over current targeted interventions, particularly over strategies that target interventions toward children closest to the decedent.

 

CIRCULATION

 

S23877060

Eating breakfast was associated with significantly lower CHD risk in this cohort of male health professionals.

S23770747

During 2.3 years of continued treatment with dabigatran after RE-LY, there was a higher rate of major bleeding with dabigatran 150 mg twice daily in comparison with 110 mg, and similar rates of stroke and death.

S23780578

RDN reduced office BP and improved relevant aspects of ambulatory BP monitoring, commonly linked to high cardiovascular risk, in patients with true-treatment resistant hypertension, whereas it only affected office BP in pseudoresistant hypertension.

S23817481

Despite progress, opportunities for improving concomitant hypertension and hypercholesterolemia control persist. Prescribing antihypertensive and antihyperlipidemic medications to achieve treatment goals, especially for older, minority, diabetic, and cardiovascular disease patients, and accessing healthcare at least biannually could improve concurrent risk factor control and CHD prevention.

S23801105

The "2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care" increased the focus on methods to ensure that high-quality cardiopulmonary resuscitation (CPR) is performed in all resuscitation attempts. There are 5 critical components of high-quality CPR: minimize interruptions in chest compressions, provide compressions of adequate rate and depth, avoid leaning between compressions, and avoid excessive ventilation. Although it is clear that high-quality CPR is the primary component in influencing survival from cardiac arrest, there is considerable variation in monitoring, implementation, and quality improvement. As such, CPR quality varies widely between systems and locations. Victims often do not receive high-quality CPR because of provider ambiguity in prioritization of resuscitative efforts during an arrest. This ambiguity also impedes the development of optimal systems of care to increase survival from cardiac arrest. This consensus statement addresses the following key areas of CPR quality for the trained rescuer: metrics of CPR performance; monitoring, feedback, and integration of the patient's response to CPR; team-level logistics to ensure performance of high-quality CPR; and continuous quality improvement on provider, team, and systems levels. Clear definitions of metrics and methods to consistently deliver and improve the quality of CPR will narrow the gap between resuscitation science and the victims, both in and out of the hospital, and lay the foundation for further improvements in the future.

S23780579

Individuals with persistently elevated BP from childhood to adulthood had increased risk of carotid atherosclerosis. This risk was reduced if elevated BP during childhood resolved by adulthood.

S23788525

Among ST-segment-elevation myocardial infarction patients identified with a prehospital ECG, the rate of ED bypass varied significantly across US hospitals, but ED bypass occurred infrequently and was mostly isolated to working hours. Because ED bypass was associated with shorter reperfusion times and numerically lower mortality rates, further exploration of and advocacy for the implementation of this process appear warranted.

 

DIABETES CARE

 

S23536582

FPG at 24-28 weeks' gestation could be used as a screening test to identify GDM patients in low-resource regions. Women with an FPG between =4.4 and =5.0 mmol/L would require a 75-g OGTT to diagnose GDM. This would help to avoid approximately one-half (50.3%) of the formal 75-g OGTTs in China.

S23645885

There is no question that incretin-based glucose-lowering medications have proven to be effective glucose-lowering agents. Glucagon-like peptide 1 (GLP-1) receptor agonists demonstrate an efficacy comparable to insulin treatment and appear to do so with significant effects to promote weight loss with minimal hypoglycemia. In addition, there are significant data with dipeptidyl peptidase 4 (DPP-4) inhibitors showing efficacy comparable to sulfonylureas but with weight neutral effects and reduced risk for hypoglycemia. However, over the recent past there have been concerns reported regarding the long-term consequences of using such therapies, and the issues raised are in regard to the potential of both classes to promote acute pancreatitis, to initiate histological changes suggesting chronic pancreatitis including associated preneoplastic lesions, and potentially, in the long run, pancreatic cancer. Other issues relate to a potential risk for the increase in thyroid cancer. There are clearly conflicting data that have been presented in preclinical studies and in epidemiologic studies. To provide an understanding of both sides of the argument, we provide a discussion of this topic as part of this two-part point-counterpoint narrative. In the point narrative below, Dr. Butler and colleagues provide their opinion and review of the data to date and that we need to reconsider the use of incretin-based therapies because of the growing concern of potential risk and based on a clearer understanding of the mechanism of action. In the counterpoint narrative following the contribution by Dr. Butler and colleagues, Dr. Nauck provides a defense of incretin-based therapies and that the benefits clearly outweigh any concern of risk. -William T. Cefalu, MD Editor In Chief, Diabetes Care.

S23645884

There is no question that incretin-based glucose-lowering medications have proven to be effective glucose-lowering agents. Glucagon-like peptide 1 (GLP-1) receptor agonists demonstrate an efficacy comparable to insulin treatment and appear to do so with significant effects to promote weight loss with minimal hypoglycemia. In addition, there are significant data with dipeptidyl peptidase 4 (DPP-4) inhibitors showing efficacy comparable to sulfonylureas but with weight neutral effects and reduced risk for hypoglycemia. However, over the recent past there have been concerns regarding the long-term consequences of using such therapies, and the issues raised are in regard to the potential of both classes to promote acute pancreatitis, to initiate histological changes suggesting chronic pancreatitis including associated preneoplastic lesions, and potentially, in the long run, pancreatic cancer. Other issues relate to an increase in thyroid cancer. There are clearly conflicting data that have been presented in preclinical studies and in epidemiologic studies. To provide an understanding of both sides of the argument, we provide a discussion of this topic as part of this two-part point-counterpoint narrative. In the point narrative preceding the counterpoint narrative below, Dr. Butler and colleagues provide their opinion and review of the data to date and that we need to reconsider use of incretin-based therapies because of the growing concern of potential risk and based on a clearer understanding of the mechanism of action. In the counterpoint narrative provided below, Dr. Nauck provides a defense of incretin-based therapies and that benefits clearly outweigh any concern of risk. -William T. Cefalu, MD Editor in Chief, Diabetes Care.

S23801791

Currently patients with diabetes comprise up to 25-30% of the census of adult wards and critical care units in our hospitals. Although evidence suggests that avoidance of hyperglycemia (>180 mg/dL) and hypoglycemia (<70 mg/dL) is beneficial for positive outcomes in the hospitalized patient, much of this evidence remains controversial and at times somewhat contradictory. We have recently formed a consortium for Planning Research in Inpatient Diabetes (PRIDE) with the goal of promoting clinical research in the area of management of hyperglycemia and diabetes in the hospital. In this article, we outline eight aspects of inpatient glucose management in which randomized clinical trials are needed. We refer to four as system-based issues and four as patient-based issues. We urge further progress in the science of inpatient diabetes management. We hope this call to action is supported by the American Diabetes Association, The Endocrine Society, the American Association of Clinical Endocrinologists, the American Heart Association, the European Association for the Study of Diabetes, the International Diabetes Federation, and the Society of Hospital Medicine. Appropriate federal research funding in this area will help ensure high-quality investigations, the results of which will advance the field. Future clinical trials will allow practitioners to develop optimal approaches for the management of hyperglycemia in the hospitalized patient and lessen the economic and human burden of poor glycemic control and its associated complications and comorbidities in the inpatient setting.

S23393215

From a health economics perspective, screening for diabetes and high-risk prediabetes should target patients at higher risk, particularly those with BMI >35 kg/m(2), systolic blood pressure =130 mmHg, or age >55 years, for whom screening can be most cost-saving. GCTpl is generally the least expensive test in high-risk groups and should be considered for routine use as an opportunistic screen in these groups.

S23404304

Exercise improves QOL in individuals with type 2 diabetes. Combined aerobic/resistance exercise produces greater benefit in some QOL domains.

 

DRUGS

 

S23839656

Since the introduction of the first meningococcal conjugate vaccines in 1999, remarkable progress has been made in reducing the morbidity and mortality caused by meningococcal disease. Currently, varying meningococcal conjugate vaccines provide protection against serogroups A, C, Y, and W meningococcal disease. A large impact has been seen after vaccine introduction, particularly in the UK after vaccinating all 1-17 year olds. The introduction of serogroup A conjugate vaccine in the meningitis belt has the potential to control epidemics of disease that disproportionately affect this area of the world. Issues remain that require continued vigilance with disease surveillance and frequent reassessment of vaccine strategies. These issues include duration of protection, potential increases in non-vaccine serogroups, and vaccine safety and potential interference with other routine vaccines. Serogroup B meningococcal vaccines are protein-based vaccines, with the first approved in early 2013. Understanding the potential impact of serogroup B vaccines is critical to developing future meningococcal vaccination strategies.

S23839658

This article provides an overview of the prevalence, pathogenesis and diagnosis of, and treatment strategies for, depression in cancer patients. Untreated depression can increase the burden of oncology symptoms and worsen the cancer prognosis through the relationship between mood and immunity. The issues to consider when treating a patient with cancer who has depression include when to introduce pharmacotherapy, the criteria for choosing an antidepressant, and the necessary caution regarding side effects and drug interactions. The choice of an antidepressant is a complex decision that has to balance previous pharmacological experiences, different clusters of target symptoms, pharmacological interactions, and objective and subjective risks of side effects, with the aim of tailoring a strategy for each patient.

S23794129

Very substantial efforts have been made over the past decade or more to develop vaccines against tuberculosis. Historically, this began with a view to replace the current vaccine, Bacillus Calmette Guérin (BCG), but more recently most candidates are either new forms of this bacillus, or are designed to boost immunity in children given BCG as infants. Good progress is being made, but very few have, as yet, progressed into clinical trials. The leading candidate has advanced to phase IIb efficacy testing, with disappointing results. This article discusses the various types of vaccines, including those designed to be used in a prophylactic setting, either alone or BCG-boosting, true therapeutic (post-exposure) vaccines, and therapeutic vaccines designed to augment chemotherapy. While there is no doubt that progress is still being made, we have a growing awareness of the limitations of our animal model screening processes, further amplified by the fact that we still do not have a clear picture of the immunological responses involved, and the precise type of long-lived immunity that effective new vaccines will need to induce.

S23754124

Atherosclerotic cardiovascular disease (CVD) is the number one cause of death globally, and lipid modification, particularly lowering of low density lipoprotein cholesterol (LDLc), is one of the cornerstones of prevention and treatment. However, even after lowering of LDLc to conventional goals, a sizeable number of patients continue to suffer cardiovascular events. More aggressive lowering of LDLc and optimization of other lipid parameters like triglycerides (TG) and high density lipoprotein cholesterol (HDLc) have been proposed as two potential strategies to address this residual risk. These strategies entail use of maximal doses of highly potent HMG CoA reductase inhibitors (statins) and combination therapy with other lipid modifying agents. Though statins in general are fairly well tolerated, adverse events like myopathy are dose related. There are further risks with combination therapy. In this article, we review the adverse effects of lipid modifying agents used alone and in combination and weigh these effects against the evidence demonstrating their efficacy in reducing cardiovascular events, cardiovascular mortality, and all cause mortality. For patients with established CVD, statins are the only group of drugs that have shown consistent reductions in hard outcomes. Though more aggressive lipid lowering with high dose potent statins can reduce rates of non fatal events and need for interventions, the incremental mortality benefits remain unclear, and their use is associated with a higher rate of drug related adverse effects. Myopathy and renal events have been a significant concern with the use of high potency statin drugs, in particular simvastatin and rosuvastatin. For patients who have not reached target LDL levels or have residual lipid abnormalities on maximal doses of statins, the addition of other agents has not been shown to improve clinical outcomes and carries an increased risk of adverse events. The clinical benefits of drugs to raise HDLc remain unproven. In patients without known cardiovascular disease, there is conflicting evidence as to the benefits of aggressive pursuit of numerical lipid targets, particularly with respect to all cause mortality. Certainly, in statin intolerant patients, alternative agents with a low side effect profile are desirable. Bile acid sequestrants are an effective and safe choice for decreasing LDLc, and omega-3 fatty acids are safe agents to decrease TG. There remains an obvious need to design and carry out large scale studies to help determine which agents, when combined with statins, have the greatest benefit on cardiovascular disease with the least added risk. These studies should be designed to assess the impact on clinical outcomes rather than surrogate endpoints, and require a comprehensive assessment and reporting of safety outcomes.

S23812923

NOACs are effective for the extended treatment of venous thromboembolism and may reduce the risk of all-cause mortality. Dabigatran and rivaroxaban may cause more major or clinically relevant bleeding.

S23775528

Peripheral artery disease (PAD) is the result of extensive atherosclerosis in the arterial supply to the lower extremities. PAD is associated with increased systemic cardiovascular morbidity and mortality as well as substantial disability due to walking impairment. Claudication is the classic symptom of leg pain with walking that is relieved by rest, but patients with PAD without typical claudication also have a walking limitation. Treatment of the patient with PAD is directed towards reducing cardiovascular risk and improving exercise capacity. The pathophysiology of the physical impairment is complex as changes in the muscle distal to the arterial stenoses contribute to the limitations. Current treatment options to improve exercise performance have limitations emphasizing the need for new pharmacotherapies for this highly prevalent condition. The multifactorial contributors to the exercise impairment in PAD suggest potential targets for novel drug therapies. Advances in understanding angiogenesis make pharmacologic revascularization possible. However, ensuring that new blood vessels develop in a distribution relevant to the clinical impairment remains a challenge. Skeletal muscle metabolism and its regulation are altered in patients with PAD and strategies to improve the efficient oxidation of fuel substrates may improve muscle function. PAD is associated with increased oxidative stress which may result in injury to the muscle microvasculature and myocyte. Minimizing this oxidative stress by enhancing cellular defense mechanisms, administration of anti-inflammatory agents or by providing antioxidants, could prevent oxidative injury. Given the central role of atherosclerosis in the flow limitation, therapies to induce regression of atherosclerotic lesions could result in improved blood flow and oxygen delivery. Drugs targeting the distribution of blood flow in the microcirculatory environment of the muscle have the potential to better match oxygen delivery with working myocytes. The physical disability and flow limitations contribute to a loss of leg muscle mass in patients with PAD. Drugs to increase muscle mass and strength could enhance walking ability in these patients. Pharmacotherapies that recapitulate the muscle adaptations induced by preconditioning may result in improved physical performance in patients with PAD. Adjunctive therapies combined with exercise training or revascularization may be important given the complexity of integrative muscle function and the multiple pathologic changes induced by PAD. New research into the pathophysiology of the physical impairment associated with PAD has identified potential new targets for drug therapy, and will likely continue to do so in the years to come. Translation of these opportunities into effective therapeutics will be important as the already high prevalence of PAD is expected to increase as the population ages.

 

EUROPEAN HEART JOURNAL

 

S23616415

Erectile dysfunction is common in the patient with cardiovascular disease. It is an important component of the quality of life and it also confers an independent risk for future cardiovascular events. The usual 3-year time period between the onset of erectile dysfunction symptoms and a cardiovascular event offers an opportunity for risk mitigation. Thus, sexual function should be incorporated into cardiovascular disease risk assessment for all men. A comprehensive approach to cardiovascular risk reduction (comprising of both lifestyle changes and pharmacological treatment) improves overall vascular health, including sexual function. Proper sexual counselling improves the quality of life and increases adherence to medication. This review explores the critical connection between erectile dysfunction and cardiovascular disease and evaluates how this relationship may influence clinical practice. Algorithms for the management of patient with erectile dysfunction according to the risk for sexual activity and future cardiovascular events are proposed.

 

FAMILY MEDICINE

 

S23846968

Nearly half of adults with type 2 DM may be at high risk for OSA, and many may be undiagnosed. In a primary care setting, the Berlin Questionnaire is an easily applied screening instrument that identifies patients at increased risk of OSA who may benefit from further diagnostic studies and treatment of OSA.

S23846965

PCPs and oncologists differ in their involvement in cancer-related follow-up care of survivors, with co-management more often reported by PCPs than by oncologists. Given anticipated national shortages of PCPs and oncologists, study results suggest that improved communication and coordination between these providers is needed to ensure optimal delivery of follow-up care to cancer survivors.

S23846967

Availability of family medicine curricular programming, formal advising/mentoring opportunities, and full-time faculty as teachers and senior administrators differed across various characteristics of medical schools. Results can be used to direct future research on medical student engagement with family medicine educational experiences relative to recruitment.

S23846966

Supporting self-management of patients with diabetes requires providers to link clinical measurements to patients' symptoms and likely outcomes. It is difficult for providers to know what support or assistance their patients need without knowledge of patients' social contexts.

 

GACETA SANITARIA

 

S23416027

Las herramientas diseñadas e implementadas por el Servicio Catalán de la Salud han demostrado ser instrumentos válidos para detectar los temas de actuación prioritarios para la mejora de la prestación de servicios y para fomentar la equidad territorial.

S23669503

«Todos los cribados hacen daño; algunos además ofrecen beneficio»16. Con este lema en mente, deberían eliminarse la mayoría de los cribados, no por su coste sino por sus perjuicios para la salud de pacientes y poblaciones17. Cabe racionalizar el cribado de la hipertensión, el neonatal de metabolopatías y el de cáncer de cuello de útero, entre otros.

S23287102

More than half the hypertensive population adhered to physical activity recommendations. To improve physical activity levels, recommendations can be tailored to the attitudes of individual patients.

S23465729

In Spain, there is increasing interest in the development of self-management support programs, although their scope is limited and their impact is mostly unknown, except for patient satisfaction. There is a need for studies on results assessment to identify the impact of these initiatives in our setting, as well as for studies on their implementation to encourage the introduction of patient activation initiatives in routine clinical practice.

 

JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE

 

S23833163

Asthma and chronic obstructive pulmonary disease (COPD) are highly prevalent chronic diseases in the general population. Both are characterized by heterogeneous chronic airway inflammation and airway obstruction. In both conditions, chronic inflammation affects the whole respiratory tract, from central to peripheral airways, with different inflammatory cells recruited, different mediators produced, and thus differing responses to therapy. Airway obstruction is typically intermittent and reversible in asthma but is progressive and largely irreversible in COPD. However, there is a considerable pathologic and functional overlap between these 2 heterogeneous disorders, particularly among the elderly, who may have components of both diseases (asthma-COPD overlap syndrome). The definitions for asthma and COPD recommended by current guidelines are useful but limited because they do not illustrate the full spectrum of obstructive airway diseases that is encountered in clinical practice. Defining asthma and COPD as separate entities neglects a considerable proportion of patients with overlapping features and is largely based on expert opinion rather than on the best current evidence. The presence of different phenotypes or components of obstructive airway diseases, therefore, needs to be addressed to individualize and optimize treatment to achieve the best effect with the fewest side effects for the patient. Although specific interventions vary by disease, the treatment goals of obstructive airway diseases are similar and driven primarily by the need to control symptoms, optimize health status, and prevent exacerbations.

S23833148

Patients are more likely to receive education if their primary care providers receive primarily capitated payment. This association is generally important for health policymakers constructing payment strategies for patient populations who would most benefit from interventions that incorporate or depend on patient education, such as populations requiring management of chronic diseases.

S23833149

Variability in UPC between providers is strongly correlated with variables that can be modified by practice managers. Our study suggests that patients assigned to nurse practitioners and physician assistants have continuity similar to those assigned to physicians.

S23833162

Reproductive health care of adolescent women is focused on prevention of disease. Adolescents are at higher risk for pelvic inflammatory disease than adult women; therefore, screening regularly for sexually transmitted infections is important. Immunization for human papillomavirus is the primary means of cervical cancer prevention because new guidelines recommend not initiating Papanicolaou smears until the age of 21. Contraception for adolescents is a challenge, and clinicians should focus on long-acting, reversible contraception in this group. The treatment of pelvic pain and menstrual disorders in adolescent women is distinct from adult women and is related to differing prevalence of conditions. Lastly, this article discusses the importance of confidential care when treating adolescent women.

S23833155

Efforts are needed to increase physicians' awareness of and adherence to PSA-based screening recommendations. Given that discussions of both advantages and disadvantages increased the uptake of PSA testing and discussion of scientific uncertainties has no effect, additional research about the nature, context, and extent of SDM and about patients' knowledge, values, and preferences regarding PSA-based screening is warranted.

 

JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

 

S23821093

Gradual reduction may not be associated with a clinically significant difference in smoking cessation rates compared with abrupt cessation.

S23917288

In this survey about health care cost containment, US physicians reported having some responsibility to address health care costs in their practice and expressed general agreement about several quality initiatives to reduce cost but reported less enthusiasm for cost containment involving changes in payment models.

S23839753

Dual antiplatelet therapy remains the cornerstone of medical therapy after PCI. Continuous advances in pharmacotherapy can further enhance our capacity to improve outcomes in this high-risk patient group.

S23917291

Among the 2 cohorts of women, a history of kidney stones was associated with a modest but statistically significantly increased risk of CHD; there was no significant association in a separate cohort of men. Further research is needed to determine whether the association is sex-specific.

 

JAMA Internal Medicine

 

S23712194

Discussions about these common tests, medications, and procedures as reported by patients do not reflect a high level of shared decision making, particularly for 5 decisions most often made in primary care.

S23877079

Musculoskeletal conditions, arthropathies, injuries, and pain are more common among statin users than among similar nonusers. The full spectrum of statins' musculoskeletal adverse events may not be fully explored, and further studies are warranted, especially in physically active individuals.

S23700076

National chain restaurants have been criticized for offering meals with excess dietary energy. This study finds that independent and small-chain restaurants, which provide no nutrition information, also provide excessive dietary energy in amounts apparently greater than popular meals from chain restaurants or information in national food databases. A national requirement for accurate calorie labeling in all restaurants may discourage menus offering unhealthy portions and would allow consumers to make informed choices about ordering meals that promote weight gain and obesity.

S23689820

Among older individuals with COPD, new use of long-acting ß-agonists and anticholinergics is associated with similar increased risks of cardiovascular events. Close monitoring of COPD patients requiring long-acting bronchodilators is needed regardless of drug class.

S23779232

Increasing red meat consumption over time is associated with an elevated subsequent risk of T2DM, and the association is partly mediated by body weight. Our results add further evidence that limiting red meat consumption over time confers benefits for T2DM prevention.

S23699927

Based on our sample, reductions in sodium levels in processed and restaurant foods are inconsistent and slow. These findings are in accord with other data indicating the slow pace of voluntary reductions in sodium levels in processed and restaurant foods. Stronger action (eg, phased-in limits on sodium levels set by the federal government) is needed to lower sodium levels and reduce the prevalence of hypertension and cardiovascular diseases.

 

JASMA Psychiatry

 

S23699867

Maternal influenza may be a risk factor for BD. Although replication is required, the findings suggest that prevention of maternal influenza during pregnancy may reduce the risk of BD.

S23699975

There is a need for increased awareness of suicide risk in individuals with certain noncancer pain diagnoses, in particular back pain, migraine, and psychogenic pain.

 

MEDICINA CLINICA

 

S22766057

La polifarmacia se asocia a menor cumplimiento y persistencia del tratamiento antihipertensivo, con aumento de ECV y costes sanitarios.

S23453921

La ecocardiografía de bolsillo realizada en atención primaria por un médico de familia, como extensión de la valoración clínica convencional en una población afectada de hipertensión arterial, permite realizar un diagnóstico precoz de lesiones cardíacas significativas, pudiendo mejorar el tratamiento de estos pacientes.

S22704275

A pesar de evidenciarse la variabilidad en los datos aportados por las distintas CCAA, así como la necesidad de mejorar la homogeneidad de los sistemas de información, en su conjunto, los indicadores evaluados de los programas de cribado de cáncer de mama alcanzan los estándares especificados en las directrices europeas.

 

MORBIDITY AND MORTALITY WEEKLY REPORT

 

S23784109

The U. S. Selected Practice Recommendations for Contraceptive Use 2013 (U.S. SPR), comprises recommendations that address a select group of common, yet sometimes controversial or complex, issues regarding initiation and use of specific contraceptive methods. These recommendations are a companion document to the previously published CDC recommendations U.S. Medical Eligibility Criteria for Contraceptive Use, 2010 (U.S. MEC). U.S. MEC describes who can use various methods of contraception, whereas this report describes how contraceptive methods can be used. CDC based these U.S. SPR guidelines on the global family planning guidance provided by the World Health Organization (WHO). Although many of the recommendations are the same as those provided by WHO, they have been adapted to be more specific to U.S. practices or have been modified because of new evidence. In addition, four new topics are addressed, including the effectiveness of female sterilization, extended use of combined hormonal methods and bleeding problems, starting regular contraception after use of emergency contraception, and determining when contraception is no longer needed. The recommendations in this report are intended to serve as a source of clinical guidance for health-care providers; health-care providers should always consider the individual clinical circumstances of each person seeking family planning services. This report is not intended to be a substitute for professional medical advice for individual patients. Persons should seek advice from their health-care providers when considering family planning options.

 

REVISTA ESPAÑOLA DE CARDIOLOGIA

 

S23721937

La fibrilación auricular es la arritmia sostenida más frecuente. Debido a sus consecuencias clínicas potencialmente graves (insuficiencia cardiaca, embolias y deterioro cognitivo), tiene importantes implicaciones socioeconómicas y sanitarias. En este artículo se revisan los principales estudios realizados para conocer la epidemiología de la fibrilación auricular en España. Los últimos datos apuntan a que en personas mayores de 40 años la prevalencia de esta arritmia puede ser superior al 4%. Dada la actual demografía española, estos datos supondrían que más de 1 millón de personas en España tendrían fibrilación auricular.

S23727072

El 20,1% de las fibrilaciones auriculares de pacientes mayores de 60 años son desconocidas previamente y no se trata con anticoagulantes al 23,5% del total.

 

THE LANCET

 

S23727171

Despite an increasing incidence of acute kidney injury in both high-income and low-income countries and growing insight into the causes and mechanisms of disease, few preventive and therapeutic options exist. Even small acute changes in kidney function can result in short-term and long-term complications, including chronic kidney disease, end-stage renal disease, and death. Presence of more than one comorbidity results in high severity of illness scores in all medical settings. Development or progression of chronic kidney disease after one or more episode of acute kidney injury could have striking socioeconomic and public health outcomes for all countries. Concerted international action encompassing many medical disciplines is needed to aid early recognition and management of acute kidney injury.

S23727169

Chronic kidney disease is defined as a reduced glomerular filtration rate, increased urinary albumin excretion, or both, and is an increasing public health issue. Prevalence is estimated to be 8-16% worldwide. Complications include increased all-cause and cardiovascular mortality, kidney-disease progression, acute kidney injury, cognitive decline, anaemia, mineral and bone disorders, and fractures. Worldwide, diabetes mellitus is the most common cause of chronic kidney disease, but in some regions other causes, such as herbal and environmental toxins, are more common. The poorest populations are at the highest risk. Screening and intervention can prevent chronic kidney disease, and where management strategies have been implemented the incidence of end-stage kidney disease has been reduced. Awareness of the disorder, however, remains low in many communities and among many physicians. Strategies to reduce burden and costs related to chronic kidney disease need to be included in national programmes for non-communicable diseases.

S23727165

In the past decade, kidney disease diagnosed with objective measures of kidney damage and function has been recognised as a major public health burden. The population prevalence of chronic kidney disease exceeds 10%, and is more than 50% in high-risk subpopulations. Independent of age, sex, ethnic group, and comorbidity, strong, graded, and consistent associations exist between clinical prognosis and two hallmarks of chronic kidney disease: reduced glomerular filtration rate and increased urinary albumin excretion. Furthermore, an acute reduction in glomerular filtration rate is a risk factor for adverse clinical outcomes and the development and progression of chronic kidney disease. An increasing amount of evidence suggests that the kidneys are not only target organs of many diseases but also can strikingly aggravate or start systemic pathophysiological processes through their complex functions and effects on body homoeostasis. Risk of kidney disease has a notable genetic component, and identified genes have provided new insights into relevant abnormalities in renal structure and function and essential homoeostatic processes. Collaboration across general and specialised health-care professionals is needed to fully address the challenge of prevention of acute and chronic kidney disease and improve outcomes.

S23727170

Since the first description of the association between chronic kidney disease and heart disease, many epidemiological studies have confirmed and extended this finding. As chronic kidney disease progresses, kidney-specific risk factors for cardiovascular events and disease come into play. As a result, the risk for cardiovascular disease is notably increased in individuals with chronic kidney disease. When adjusted for traditional cardiovascular risk factors, impaired kidney function and raised concentrations of albumin in urine increase the risk of cardiovascular disease by two to four times. Yet, cardiovascular disease is frequently underdiagnosed and undertreated in patients with chronic kidney disease. This group of patients should, therefore, be acknowledged as having high cardiovascular risk that needs particular medical attention at an individual level. This view should be incorporated in the development of guidelines and when defining research priorities. Here, we discuss the epidemiology and pathophysiological mechanisms of cardiovascular risk in patients with chronic kidney disease, and discuss methods of prevention.

S23706508

Our results show the importance of adequate iodine status during early gestation and emphasise the risk that iodine deficiency can pose to the developing infant, even in a country classified as only mildly iodine deficient. Iodine deficiency in pregnant women in the UK should be treated as an important public health issue that needs attention.

S23643112

This moderately intense exercise programme did not reduce depressive symptoms in residents of care homes. In this frail population, alternative strategies to manage psychological symptoms are required.

S23727164

Although in some parts of the world acute and chronic kidney diseases are preventable or treatable disorders, in many other regions these diseases are left without any care. The nephrology community needs to commit itself to reduction of this divide between high-income and low-income regions. Moreover, new and exciting developments in fields such as pharmacology, genetic, or bioengineering, can give a boost, in the next decade, to a new era of diagnosis and treatment of kidney diseases, which should be made available to more patients.

S23683600

Combined teriparatide and denosumab increased BMD more than either agent alone and more than has been reported with approved therapies. Combination treatment might, therefore, be useful to treat patients at high risk of fracture.

S23598181

Our findings can inform further research on brief counselling for women disclosing intimate partner violence in primary care settings, but do not lend support to the use of postal screening in the identification of those patients. However, we suggest that family doctors should be trained to ask about the safety of women and children, and to provide supportive counselling for women experiencing abuse, because our findings suggest that, although we detected no improvement in quality of life, counselling can reduce depressive symptoms.

 

THE NEW ENGLAND JOURNAL OF MEDICINE

 

S23803136

Among patients with TIA or minor stroke who can be treated within 24 hours after the onset of symptoms, the combination of clopidogrel and aspirin is superior to aspirin alone for reducing the risk of stroke in the first 90 days and does not increase the risk of hemorrhage.

S23841730

Declines in hospitalizations for childhood pneumonia were sustained during the decade after the introduction of PCV7. Substantial reductions in hospitalizations for pneumonia among adults were also observed.

 

THORAX

 

S23589509

Our findings add to the expanding body of evidence that smokefree policies are associated with positive health outcomes. Further research evaluating the impact of legislation in other jurisdictions is needed to support these findings.

S23564399

Regular electronic monitoring of PEF and asthma symptoms provides an acceptable sensitivity and specificity for the detection of SEs and may be suitable for personal internet-based monitoring of asthma control.

 

 

 

 

                      

XXVIII Congreso de Comunicación y Salud

 

 

semFYC - JRT 2017

 

Cáceres, 10 y 11 de Noviembre 2017


____________________________

 Para pacientes
@pontealdiaAP
 @pontealdiaURG
55 e.SAMFyC

 


 

semFYC
 

 

Estadisticas

Ver contenido por hits : 1101636



La SAMFyC:
 C/ Arriola, 4, bajo D, CP.18001 - Granada. Email: samfyc@samfyc.es; Teléfono: 958 804 201 - Fax: 958 804 202. Horario de invierno: lunes a jueves de 9:00 a 17:30 horas; viernes de 9:00 a 14:30 horas. Horario de verano: lunes a viernes de 8:00 a 15:00h. Todos los derechos reservados. Aviso Legal. 


¡CSS Válido!

Diseño web